The effect of gemfibrozil on lipid profile and glucose metabolism in hypertriglyceridaemic well-controlled non-insulin-dependent diabetic patients
暂无分享,去创建一个
[1] M. Laakso,et al. Treatment of Hypercholesterolemia and Combined Hyperlipidemia With Simvastatin and Gemfibrozil in Patients With NIPPM: A multicenter comparison study , 1998, Diabetes Care.
[2] S. Haffner. Management of Dyslipidemia in Adults With Diabetes , 1998, Diabetes Care.
[3] L. Mandarino,et al. Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM. , 1996, The American journal of physiology.
[4] G. Dagenais,et al. Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Québec cardiovascular study. , 1996, Atherosclerosis.
[5] D. Bell. A comparison of lovastatin, an HMG-CoA reductase inhibitor, with gemfibrozil, a fibrinic acid derivative, in the treatment of patients with diabetic dyslipidemia. , 1995, Clinical therapeutics.
[6] G. Lewis. Diabetic dyslipidemia: a case for aggressive intervention in the absence of clinical trial and cost effectiveness data. , 1995, Canadian Journal of Cardiology.
[7] A. Avogaro,et al. Insulin action and glucose metabolism are improved by gemfibrozil treatment in hypertriglyceridemic patients. , 1995, Atherosclerosis.
[8] D. Bhatnagar,et al. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia. , 1994, European journal of clinical nutrition.
[9] G. Steiner. Dyslipoproteinemias in diabetes. , 1994, Clinical and investigative medicine. Medecine clinique et experimentale.
[10] M D Jensen,et al. In vivo regulation of lipolysis in humans. , 1994, Journal of lipid research.
[11] M. Taskinen,et al. Gemfibrozil reduces postprandial lipemia in non-insulin-dependent diabetes mellitus. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.
[12] J. Huttunen,et al. Coronary Heart Disease Incidence in NIDDM Patients In The Helsinki Heart Study , 1992, Diabetes Care.
[13] G. Steiner. Altering Triglyceride Concentrations Changes Insulin-Glucose Relationships in Hypertriglyceridemic Patients: Double-Blind Study With Gemfibrozil With Implications for Atherosclerosis , 1991, Diabetes Care.
[14] G. Reaven,et al. Effect of gemfibrozil treatment in sulfonylurea-treated patients with noninsulin-dependent diabetes mellitus. , 1991, The Journal of clinical endocrinology and metabolism.
[15] J. Huttunen,et al. Effect of gemfibrozil on the concentration and composition of serum lipoproteins. A controlled study with special reference to initial triglyceride levels. , 1990, Atherosclerosis.
[16] Y. Tani,et al. Enzymatic microdetermination of serum free fatty acids. , 1979, Analytical biochemistry.
[17] P. Dunn,et al. A rapid method for the determination of glycosylated hemoglobins using high pressure liquid chromatography. , 1978, Metabolism: clinical and experimental.
[18] D L Horwitz,et al. Determination of Free and Total Insulin and C-Peptide in Insulin-treated Diabetics , 1977, Diabetes.
[19] G. Kostner. Letter: Enzymatic determination of cholesterol in high-density lipoprotein fractions prepared by polyanion precipitation. , 1976, Clinical chemistry.
[20] G. Reaven,et al. Reappraisal of the role of insulin in hypertriglyceridemia. , 1974, The American journal of medicine.
[21] E. Horton. NIDDM--the devastating disease. , 1995, Diabetes research and clinical practice.
[22] P. Allhoff,et al. Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle Aged Men with Dyslipidemia , 1991 .
[23] L. Amorosa,et al. Management of noninsulin-dependent diabetes mellitus. , 1980, American family physician.
[24] M. Knob,et al. Enzymatische Bestimmung des Gesamtcholesterins im Serum mit Zentrifugalanalyzern , 1975 .
[25] A. Wahlefeld. Triglycerides Determination after Enzymatic Hydrolysis , 1974 .